BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15466175)

  • 21. [Methylation status and protein expression of adenomatous polyposis coli (APC) gene in breast cancer].
    Liu Z; Yang L; Cui DX; Liu BL; Zhang XB; Ma WF; Zhang Q
    Ai Zheng; 2007 Jun; 26(6):586-90. PubMed ID: 17562262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Frequency and significance of APC gene mutations in malignant degeneration of Barrett esophagus].
    Stöltzing O; Schneider PM; Becker K; Wegerer S; Siewert JR; Hölscher AH
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):485-9. PubMed ID: 14518303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells.
    Akiyama Y; Maesawa C; Ogasawara S; Terashima M; Masuda T
    Am J Pathol; 2003 Nov; 163(5):1911-9. PubMed ID: 14578190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent hypermethylation of the 5' CpG island of E-cadherin in esophageal adenocarcinoma.
    Corn PG; Heath EI; Heitmiller R; Fogt F; Forastiere AA; Herman JG; Wu TT
    Clin Cancer Res; 2001 Sep; 7(9):2765-9. PubMed ID: 11555590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of adenomatous polyposis coli (APC) gene in testicular yolk sac tumor of infants.
    Kato N; Shibuya H; Fukase M; Tamura G; Motoyama T
    Hum Pathol; 2006 Jan; 37(1):48-53. PubMed ID: 16360415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylation of the adenomatous polyposis coli (APC) gene in human placenta and hypermethylation in choriocarcinoma cells.
    Wong NC; Novakovic B; Weinrich B; Dewi C; Andronikos R; Sibson M; Macrae F; Morley R; Pertile MD; Craig JM; Saffery R
    Cancer Lett; 2008 Sep; 268(1):56-62. PubMed ID: 18485586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter methylation profile in preneoplastic and neoplastic gallbladder lesions.
    García P; Manterola C; Araya JC; Villaseca M; Guzmán P; Sanhueza A; Thomas M; Alvarez H; Roa JC
    Mol Carcinog; 2009 Jan; 48(1):79-89. PubMed ID: 18543280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Methylation quantification of adenomatous polyposis coli (APC) gene promoter in plasma of lung cancer patients].
    Pan SY; Xie EF; Shu YQ; Gao L; Zhang LX; Chen D; Chen JB; Zhao WJ; Mu Y; Zhang JN
    Ai Zheng; 2009 Apr; 28(4):384-9. PubMed ID: 19622298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factor binding protein-3 gene methylation and protein expression in gastric adenocarcinoma.
    Gigek CO; Leal MF; Lisboa LC; Silva PN; Chen ES; Lima EM; Calcagno DQ; Assumpção PP; Burbano RR; Smith Mde A
    Growth Horm IGF Res; 2010 Jun; 20(3):234-8. PubMed ID: 20219400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation analysis of the adenomatous polyposis coli (APC) gene in adult T-cell leukemia/lymphoma.
    Yang Y; Takeuchi S; Tsukasaki K; Yamada Y; Hata T; Mori N; Fukushima A; Seo H; Koeffler HP; Taguchi H
    Leuk Res; 2005 Jan; 29(1):47-51. PubMed ID: 15541474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of early Barrett's adenocarcinoma repeatedly developing multiple metachronous lesions shortly after endoscopic therapy: an analysis for genetic and epigenetic alterations.
    Watari J; Sakurai J; Morita T; Yamazaki T; Okugawa T; Toyoshima F; Tanaka J; Tomita T; Kim Y; Oshima T; Hori K; Moriichi K; Tanabe H; Fujiya M; Kohgo Y; Das KM; Matsumoto T; Miwa H
    Gastrointest Endosc; 2010 Dec; 72(6):1303-7. PubMed ID: 20650453
    [No Abstract]   [Full Text] [Related]  

  • 32. [Genome analyses for precancerous lesions in the gastrointestinal tract].
    Sowa M; Nakata B
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):335-40. PubMed ID: 10740625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Fontolliet C; Bosman FT; Benhattar J
    Gastroenterology; 2002 Apr; 122(4):1113-21. PubMed ID: 11910361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis.
    Lee OJ; Schneider-Stock R; McChesney PA; Kuester D; Roessner A; Vieth M; Moskaluk CA; El-Rifai W
    Neoplasia; 2005 Sep; 7(9):854-61. PubMed ID: 16229808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterations.
    Hardie LJ; Darnton SJ; Wallis YL; Chauhan A; Hainaut P; Wild CP; Casson AG
    Cancer Lett; 2005 Jan; 217(2):221-30. PubMed ID: 15617840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression.
    Song Y; Zhang C
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):605-13. PubMed ID: 18521605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
    Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
    Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
    Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
    Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression profile of malignant and nonmalignant lesions of esophagus and stomach: differential activity of functional modules related to inflammation and lipid metabolism.
    Gomes LI; Esteves GH; Carvalho AF; Cristo EB; Hirata R; Martins WK; Marques SM; Camargo LP; Brentani H; Pelosof A; Zitron C; Sallum RA; Montagnini A; Soares FA; Neves EJ; Reis LF
    Cancer Res; 2005 Aug; 65(16):7127-36. PubMed ID: 16103062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.